drugset / Trial / NCT06901726
Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males
RandomizedCrossoverOpen-labelTreatment
Summary
Pharmacokinetics and pharmacodynamics study of 2 formulations (human insulin enteric coated capsules 32mg vs. human insulin injection 5IU) Relative biopotency and bioavailability of human insulin enteric coated capsules 32mg vs. human insulin injection 5IU
Timeline
- Start
- 2025-03-31
- Primary completion
- 2025-04-24
- Completion
- 2025-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 5 iu | Oral |
| Subject | Insulin | Protein / enzyme biologic | 32 mg | Oral |